Therapeutics: DNA (cytosine-5-)-methyltransferase 3β (DNMT3B)

Patient sample, cell culture and mouse studies suggest inhibiting DNMT3B could help treat melanoma. In patients, high tumor levels of DNMT3B correlated with poor overall survival, and DNMT3B levels we...